• where experts go to learn about FDA
  • Month: October 2013

    • Repairing the U.S. Cancer Care Delivery System: Should It Include a New Exclusivity Incentive?October 16th, 2013

      By Kurt R. Karst –       We’ve previously noted the resurgence of interest in (and controversy over) brand-side exclusivity.  There’s the QI Program Supplemental Funding Act of 2008 (Pub. L. No. 110-379), which gave new life to “old” antibiotics.  FDC Act § 505(u), titled “Certain Drugs …

    • AMI Appeals District Court’s Denial of Preliminary Injunction against COOL RegulationsOctober 16th, 2013

      By Riëtte van Laack – As previously reported, the American Meat Institute (“AMI”) and several international meat industry organizations filed a lawsuit in an effort to stop the Agricultural Marketing Service ("AMS") of the USDA from implementing the Country of Origin Labeling ("COOL") rule.  On …

    • Biosimilar Substitution Bill Opposition Strikes Gold in California: Governor Brown Vetoes the MeasureOctober 15th, 2013

      By Kurt R. Karst – On October 12th, California Governor Jerry Brown finally acted on Senate Bill 598, vetoing the measure.  If enacted, the bill would have amended California’s Pharmacy Law to require, among other things, a pharmacy to notify a prescriber within 5 business days whether …

    • Move Over, Cricket! Lickets: Edible Insects are On the MarchOctober 13th, 2013

      By Ricardo Carvajal – People have been eating insects for thousands of years, and the practice certainly has its devotees in the U.S.  Notwithstanding that history of consumption, industrial production of insects for food use has remained a rarity.  Now there are signs of a …

    • California Court Decides that the Organic Food Production Act Does Not Apply to Personal Care ProductsOctober 10th, 2013

      By Riëtte van Laack – In May of 2012, Plaintiff Matthew Dronkers filed a complaint in the United States District Court for the Southern District of California, on behalf of himself and other class members against Kiss My Face, LLC (“KMF”) claiming that KMF’s marketing …

    • As Maine’s Drug Importation Law Goes Into Effect, State Seeks Dismissal of Lawsuit to Block ImplementationOctober 9th, 2013

      By Kurt R. Karst –   We were reminded earlier today that a new law has gone into effect in the state of Maine permiting the importation of drug products into the state from licensed retail pharmacies located in certain foreign countries.  As we previously reported, …

    • CDRH Details Relaxed Data Standard for IDEs for Early Feasibility StudiesOctober 8th, 2013

      By Jay W. Cormier – Notwithstanding the government shutdown, on Tuesday, October 1st, FDA’s Center for Devices and Radiological Health (“CDRH”) issued a final guidance regarding filing for an investigational device exemption (“IDE”) for medical device early feasibility studies.  At the heart of the guidance is that …

    • The Shutdown: An Update on FDA ActivitiesOctober 7th, 2013

      By Kurt R. Karst –       We’re now entering the second week of the shutdown of the federal government (or “the lapse period” as some have called it), and there does not appear to be an end in sight.  In fact, the environment in Washington, D.C. has …

    • Free the FDAAA Hostage!October 7th, 2013

      By Jeffrey K. Shapiro – There has been a lot of talk about hostage taking during the recent federal government budget impasse.  But Congress is not the only one taking hostages in Washington.  The recent draft Medical Device Reporting (MDR) guidance reminds us (pp. 4-5) …

    • Former White House Fellow Kermit L. Jones, J.D., M.D. Joins Hyman, Phelps & McNamara, P.C.October 7th, 2013

      Hyman, Phelps & McNamara, P.C. is pleased to announce that Kermit L. Jones, J.D., M.D. has joined the firm as an Associate.  Prior to joining the firm, Dr. Jones served as a 2012-2013 White House Fellow assigned to the Secretary of Health and Human Services, …

    • $5 Million Later, Truvia® is Still “Natural”October 4th, 2013

      By Riëtte van Laack & Ricardo Carvajal – On September 19, 2013, Cargill entered into a $5 million settlement agreement to dispose of a class action lawsuit regarding its advertising for Truvia® products as “natural.”  Plaintiffs charged that the products are not natural because they …

    • Non-Designated Uses of Orphan Drugs – To 340B or Not to 340B?October 2nd, 2013

      By Jay Cormier & Alan Kirschenbaum – The Patient Protection and Affordable Care Act made extensive changes to the 340B drug discount program, which we have previously described.  Among other things, the statute expanded the categories of covered entities entitled to purchase drugs at the …

    • An Old Fashioned Park Criminal Prosecution With Some TwistsOctober 2nd, 2013

      By John R. Fleder – On September 26, 2013, the United States Attorney for the District of Colorado announced that he had filed a six count criminal Information against Eric and Ryan Jensen.  The government alleges that the defendants violated the FDC Act by introducing adulterated …

    • FDA Flexes GDUFA Enforcement Muscle; Issues First Warning Letter to Non-Compliant Manufacturing FacilityOctober 2nd, 2013

      By Kurt R. Karst –    It was not a question of whether, but when FDA would issue its first Warning Letter to a facility covered by the Generic Drug User Fee Amendments of 2012 (“GDUFA”) that failed to self-identify its facility and pay applicable user fees.  …

    • As Partial Government Shutdown Kicks In, FDA’s Foods Program Is Hardest HitOctober 1st, 2013

      By Ricardo Carvajal & Kurt R. Karst – According to contingency plans drawn up by the Department of Health and Human Services, 45% of FDA’s nearly 15,000 staff were to be furloughed in the absence of enacted annual appropriations – popularly referred to as a …